| View |
|
DRP-12592-04
|
Cefixime (as trihydrate)
|
Bioxime
|
20 mg/mL
|
Powder for Oral Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Private Limited
|
India
|
CLIDP Conversion
|
10 June 2024
|
19 September 2027
|
| View |
|
DRP-12738-09
|
Telmisartan + Amlodipine (as besilate)
|
Zamplify 40/5
|
40 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
11 June 2024
|
30 September 2027
|
| View |
|
DRP-12788-04
|
Omeprazole
|
Giprazole
|
40 mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 June 2024
|
07 October 2027
|
| View |
|
DRP-12854-03
|
Cefuroxime (as axetil)
|
Cerin-250
|
250 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 June 2024
|
28 October 2027
|
| View |
|
DRP-12894-04
|
Gliclazide
|
Gliclasy 80
|
80 mg
|
Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 June 2024
|
25 January 2027
|
| View |
|
DRP-12894-06
|
Gliclazide
|
Glizen 80
|
80 mg
|
Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
14 June 2024
|
25 January 2027
|
| View |
|
DRP-12908-01
|
Celecoxib
|
Coxilife
|
400 mg
|
Capsule
|
Non-Steroid Antiinflammatory and Antirheumatic Product (Coxib)
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
12 June 2024
|
27 October 2027
|
| View |
|
DRP-12921-04
|
Co-Amoxiclav
|
Clavulife 250
|
312.5 mg / 5 mL
|
Powder for Oral Suspension (Orange Flavor)
|
Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
|
Yeluri Formulations Pvt Ltd
|
India
|
CLIDP Conversion
|
15 June 2024
|
28 October 2027
|
| View |
|
DRP-12952-01
|
Cetirizine (as Dihydrochloride)
|
Histagic
|
10 mg
|
Tablet
|
Antihistamine
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
10 June 2024
|
09 December 2027
|
| View |
|
DRP-13056-01
|
Losartan Potassium
|
Retazar
|
50 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Kopran Limited
|
India
|
CLIDP Conversion
|
15 June 2024
|
23 November 2027
|
| View |
|
DRP-13102-02
|
Celecoxib
|
Celehil
|
200 mg
|
Capsule
|
Non-Steroidal Anti-inflammatory and Antirheumatic
|
Gracure Pharmaceutical Ltd
|
India
|
CLIDP Conversion
|
10 June 2024
|
01 December 2027
|
| View |
|
DRP-13155-01
|
Pregabalin
|
Gablin
|
150 mg
|
Capsule
|
Antiepileptic
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 June 2024
|
12 December 2027
|
| View |
|
DRP-13157-03
|
Levothyroxine sodium
|
Eploxin 50
|
50 mcg
|
Tablet
|
Thyroid Hormone
|
Sterile-Gene Life Sciences (P) Ltd.
|
India
|
CLIDP Conversion
|
11 June 2024
|
12 December 2027
|
| View |
|
DRP-1317-09
|
Cetirizine Dihydrochloride
|
Aforvir
|
1 mg / mL
|
Oral Solution
|
Antihistamine (Piperazine Derivative)
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
15 June 2024
|
04 May 2027
|
| View |
|
DRP-13209-04
|
Pregabalin
|
Gablin
|
75mg
|
Capsule
|
Antiepileptic
|
Titan Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 June 2024
|
29 December 2027
|
| View |
|
DRP-13209-05
|
Pregabalin
|
Medirica
|
75 mg
|
Capsule
|
Antiepileptic
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
14 June 2024
|
29 December 2027
|
| View |
|
DRP-13237-08
|
Ursodeoxycholic Acid
|
Zurso
|
500 mg
|
Film-Coated Tablet
|
Bile Acid and Derivative
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 June 2024
|
06 January 2028
|
| View |
|
DRP-13350-01
|
Dydrogesterone
|
Dydrotone
|
10 mg
|
Film-Coated Tablet
|
Progestogen( Pregnadien Derivative)
|
Par Laboratories
|
India
|
CLIDP Conversion
|
15 June 2024
|
01 February 2025
|
| View |
|
DRP-13462-01
|
Acetylcysteine
|
Flusoothin
|
600 mg
|
Effervescent Tablet (Orange Flavor)
|
Mucolytic
|
Vovantis Laboratories Private Limited
|
India
|
CLIDP Conversion
|
10 June 2024
|
23 February 2026
|
| View |
|
DRP-13484-01
|
Duloxetine (as hydrochloride)
|
Joytor-30
|
30 mg
|
Delayed Release Capsule
|
Prescription Drug (Rx)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 June 2024
|
27 February 2028
|